Fairtree Asset Management Pty Ltd Acquires 11,509 Shares of Zoetis Inc. $ZTS

Fairtree Asset Management Pty Ltd grew its holdings in Zoetis Inc. (NYSE:ZTS) by 252.3% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 16,071 shares of the company’s stock after buying an additional 11,509 shares during the quarter. Zoetis comprises approximately 1.5% of Fairtree Asset Management Pty Ltd’s portfolio, making the stock its 15th largest holding. Fairtree Asset Management Pty Ltd’s holdings in Zoetis were worth $2,352,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ZTS. Halbert Hargrove Global Advisors LLC raised its stake in shares of Zoetis by 496.6% in the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after acquiring an additional 144 shares during the last quarter. NewSquare Capital LLC increased its holdings in shares of Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after purchasing an additional 85 shares in the last quarter. Financial Consulate Inc. bought a new position in Zoetis in the 3rd quarter worth approximately $39,000. SJS Investment Consulting Inc. lifted its holdings in Zoetis by 1,606.3% during the 3rd quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock worth $40,000 after buying an additional 257 shares in the last quarter. Finally, TruNorth Capital Management LLC acquired a new position in Zoetis during the 3rd quarter worth $42,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the subject of a number of recent research reports. JPMorgan Chase & Co. dropped their target price on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. KeyCorp started coverage on Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating for the company. Stifel Nicolaus cut their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Tuesday, November 18th. UBS Group set a $136.00 target price on shares of Zoetis in a research note on Thursday, January 29th. Finally, The Goldman Sachs Group upgraded shares of Zoetis to a “buy” rating in a research report on Monday, December 15th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Zoetis currently has a consensus rating of “Hold” and a consensus target price of $152.91.

Zoetis Price Performance

Shares of ZTS opened at $131.06 on Monday. The stock has a market cap of $55.32 billion, a P/E ratio of 21.77, a price-to-earnings-growth ratio of 2.00 and a beta of 0.95. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.00. The stock’s 50-day moving average price is $126.05 and its two-hundred day moving average price is $133.92. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The business had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.36 billion. During the same period last year, the company posted $1.40 EPS. Zoetis’s revenue for the quarter was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, equities analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio (DPR) is currently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.